Arbor Rapha Capital Bioholdings Corp. I (ARCK) Stock Analysis

What Arbor Rapha Capital Bioholdings Corp. I does

Arbor Rapha Capital Bioholdings Corp. I currently operates without substantial business activities. Its core mission is to identify and finalize a strategic business combination, which could involve a merger, stock exchange, asset purchase, or corporate reorganization, with another entity or entities. The firm specifically targets acquisition opportunities within the biopharmaceutical sector. Established in 2021, its headquarters are located in Uniondale, New York.

Key metrics

ETFs linked to ARCK

Broad-market and Financial Services sector ETFs an investor holding Arbor Rapha Capital Bioholdings Corp. I is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ARCK fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Arbor Rapha Capital Bioholdings Corp. I?

Arbor Rapha Capital Bioholdings Corp. I trades under the ticker ARCK on NASDAQ.

Which exchange is ARCK listed on?

ARCK is listed on NASDAQ.

What sector does Arbor Rapha Capital Bioholdings Corp. I operate in?

Arbor Rapha Capital Bioholdings Corp. I is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze ARCK in a portfolio?

PortView shows ARCK's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.